Derk Jan D. G.
- Country
- The Netherlands
- Department
- Department of Medical Oncology / Room Z3.18
Research Overview
- Evaluation of Safety, Tolerability, and PET Imaging Effects of GEH200520 and GEH200521 (18F) in Patients with Irresectable or Metastatic Solid Tumors
- Phase III Trial of BI 764532 Plus Carboplatin and Etoposide Versus Carboplatin and Etoposide in Previously Untreated DLL3-Positive Advanced Extrapulmonary Neuroendocrine Carcinoma
- Phase II Basket Trial of Atezolizumab and Tiragolumab in Patients with Solid Tumors, Including HNSCC, dMMR/MSI-H Tumors, and Metastatic Melanoma
Data & Insights
Has run more than one trial at 15 of 117 partner sites.
Specializations
Neuroendocrine Cancer Research
This investigator specializes in treating various forms of neuroendocrine carcinomas, including extra-pulmonary neuroendocrine carcinoma and large cell neuroendocrine carcinoma of pulmonary origin.
- Primary and Unknown Origin NECs
- Advanced Stage Treatment
- Combination Therapy Approaches
Pancreatic Cancer Treatment
The investigator focuses on innovative treatment approaches for resectable pancreatic cancer, exploring both perioperative and adjuvant therapeutic strategies using modified FOLFIRINOX protocols.
- Surgical Intervention Timing
- Survival Outcome Optimization
- Non-metastatic Disease Management
Advanced Solid Tumors
This specialist works with various solid tumor types, particularly focusing on head and neck squamous cell carcinoma and metastatic melanoma. Their expertise extends to innovative imaging techniques and immunotherapy approaches.
- Novel Imaging Methods
- Immunotherapy Applications
- Multi-Modal Treatment Strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.